Misleading ads case: Patanjali MD Acharya Balkrishna submits apology to Supreme Court [21.3.2024]

Patanjali Ayurved and its Managing Director Acharya Balkrishna has submitted an official apology to the Supreme Court regarding its misleading advertisements targeting evidence-based medicine.

In an affidavit submitted to the Supreme Court, Balkrishna assured that such advertisements would not be released in the future. He emphasised that the company's sole intention is to encourage citizens to adopt a healthier lifestyle by using products from Patanjali Ayurved.

The affadavit further claimed that Patanajali Ayurved products were backed by scientific research that were not available during the enactment of the Drugs and Cosmetics Act of 1940. Moreover, he stated that Patanjali Ayurved products and Ayurveda itself were backed by knowledge in ancient literature.

Balkrishna affirmed that Patanjali would refrain from repeating misleading ads and that the firm's intention was solely aimed at promoting Ayurveda.

Patanjali, in its affidavit, expressed utmost respect for the rule of law and committed to abiding by it. The company stated that its media division was unaware of any court proceedings prohibiting such advertisements.


21 Mar 2024